Biotech Breakthrough Alert! ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
|
A message from Sideways Frequency, LLC |
The future belongs to regenerative medicine, and BioStem Technologies (OTC: BSEM) is emerging as a trailblazer driving innovation, rapid revenue growth, and groundbreaking advancements. The company develops regenerative therapies using perinatal tissue for advanced wound care through its proprietary BioREtain® technology. Several positive news announcements are reflecting the tremendous growth potential of BSEM.
The company recently announced record preliminary net revenue of $72.5 million for Q1 2025 — a 73% increase from $41.9 million in Q1 2024 — and ended the quarter with $26.7 million cash on hand (up from $22.8 million on December 31st, 2024). This was the strongest first quarter in the company’s history! BSEM is also actively reviewing its Form 10 registration with the SEC and aims for a Nasdaq uplisting. Being listed on the NASDAQ would open up the stock to new investors, especially on the institutional front!
Jason Matuszewski, CEO and Chairman of BSEM, was recently named an Entrepreneur Of The Year 2025 Florida Award winner ! Winning this award highlights his leadership and vision. This signals BSEM is led by a proven, respected entrepreneur vetted for growth and innovation—an important indicator of long-term potential. He now advances to the national competition with a chance to represent the U.S. globally in 2026. This award and increased visibility through Ernst & Young could boost BSEM’s momentum and stock value. This message is a PAID ADVERTISEMENT for BioStem Technologies Inc (OTC: BSEM) from Sideways Frequency. StockEarnings, Inc. has received a fixed fee of $6000 from Sideways Frequency for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between July 14, 2025 and July 18, 2025. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either BioStem Technologies Inc (OTC: BSEM) or Sideways Frequency. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding BioStem Technologies Inc (OTC: BSEM) on Huge Alerts website for additional information about the relationship between Sideways Frequency and BioStem Technologies Inc (OTC: BSEM). Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click Unsubscribe.
StockEarnings, Inc 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA W: 877.6.STOCKS StockEarnings.com
|
|
|
|